REGISTERED
on 03 Sep 2024
Last Applicant/ Owned by
2131 Felver Court, Suite A
Rahway
NJ
07065
Serial Number
90839896 filed on 21st Jul 2021
Registration Number
7495809 registered on 03rd Sep 2024
Correspondent Address
Michael C. Cannata
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
OMNIVIUM PHARMACEUTICALS
pharmaceutical products and preparations for curing, halting and preventing cardiovascular, bacterial, viral, psychiatric, eye, central nervous system, gastrointestinal, and cancer related diseases, easing symptoms, or helping in the diagnosis of illnesses; house mark for a full line of pharmaceuticals
Classification Information
Class [005]
Pharmaceutical Products
pharmaceutical products and preparations for curing, halting and preventing cardiovascular, bacterial, viral, psychiatric, eye, central nervous system, gastrointestinal, and cancer related diseases, easing symptoms, or helping in the diagnosis of illnesses; house mark for a full line of pharmaceuticals
First Use Date in General
15th Oct 2023
First Use Date in Commerce
15th Oct 2023
Mark Details
Serial Number
No 90839896
Mark Type
No Service Mark
Attorney Docket Number
No 9943-6
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.01.05 -
Circles made of broken or dotted lines
26.01.12 -
Circles with bars, bands and lines
26.17.01 -
Straight line(s), band(s) or bar(s)
26.17.04 -
Vertical line(s), band(s) or bar(s)
Legal History
| Status Date | Action Taken |
|---|---|
| 03rd Sep 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 03rd Sep 2024 | REGISTERED-PRINCIPAL REGISTER |
| 31st Jul 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 31st Jul 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 30th Jul 2024 | ASSIGNED TO LIE |
| 30th Jul 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 30th Jul 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 09th Feb 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 28th Dec 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 28th Dec 2023 | NON-FINAL ACTION E-MAILED |